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1140-49 The Safety  of  Cl in ical  Card iovascu lar  Magnetic 
Resonance Imaging: A Single-Center Experience in 
More Than 3,000 Cases 
Matthias G. Fdedrich. Jeanette Schulz-Menger, Oliver Strohm, Wolfgang Lankes, 
Thomas Poetsch, Rainer Dietz, Franz-Volhard-Klinik, Charite, Humboldt-Universitaet 
Berlin, Berlin, Germany. 
Cardiovascular magnetic resonance imaging (MRI) is increasingly used in clinical cardi- 
ology, also in patients with decreased LV function, errhythmia, or other risk factors. Thus, 
the assessment of safety is important o evaluate the clinical rote of MRI. 
Between January 1996 and March 2001 we included 3326 clinical cardiovascular MRI 
studies requested in our University cardiology department. The MRI department is 
equipped with emergency tools and a removable table. Cardiologists, experienced in 
resuscitation, are always present. 
221 studies (6.6%) could not be performed because of severe claustrophobia (157/4.7%) 
or contraindications (56/1.7%). The remaining studies included 170 patients with severe 
symptoms such as dypnea, angina during the last 6 hours and 21 clinically unstable 
patients suffering from acute myocardial infarction, acute aortic dissection, or unstable 
angina. In eight patients (0.24%) the study had to be terminated because of severe dysp- 
nea. An adverse event occurred in three of 2008 studies (0.15%) with intravenous admin- 
istration of Gd-DTPA, characterized by unspecific symptoms in one case, rash in another 
case and an allergic reaction with a drop in blood pressure in the third. In two patients, 
severe arrhythmia occurred during the study (complete AV block in one case and a non- 
sustained VT in another case), both during stress studies (2/155 = 1.7%) and both with a 
self-limiting course. No death or other disabling adverse event occurred. 
We conclude that cardiovascular MRI can be performed in cardiologic patients with a 
high level of safety. When emergency equipment and skilled presennel is present, this 
technique can be offered to patients with an increased cardiovascular risk. 
1140-50 Criter ia for  Concent r i c  Left  Ventr icu lar  Geometry 
Determined Using Magnetic Resonance Imaging 
Michael L. Chuano, Carol J. Salton, Christopher J. O'Donnelt, Kraig V. Kissinger, Daniel 
Levy, Warren J. Manning, Beth israel Deaconess Medical Center, Boston, 
Massachusetts, NHLBI's Framingham Heart Study, Framingham, Massachusetts. 
Left ventricular (LV) concentric geometry (CONC), which includes concentric remodeling 
(in persons without elevated LV mass) and concentric hypertrophy (elevated mass), is 
associated with increased cardiovascular risk and is echocardiographically defined by a 
wall thickness-to-cavity radius ratio (WTCR)>=0.45. Criteda for CONC using volumetric 
measures have not been defined. We compared a volumetric index, the LV mass to end- 
diastolic volume (EDV) ratio (MVR), to the linear WTCR for stratification of a population- 
based sample for CONC. 
METHODS 
Contiguous rnultislice breathhold cine MRI (Philips Gyroscan NT) was used to determine 
volumetric LV EDV, volumetric LV mass, basal anterior septal wall thickness and LV end- 
diastolic diameter in 292 adults (141 men, 151 women, aged 59±9 yrs) without symptom- 
atic cardiac disease from the Framingham Heart Study Offspring Cohort. Subjects were 
stratified by quartile of CONC using MVR and WTCR. Interquartile crossovers were tabu- 
lated. Subjects also were ranked by CONC and correlation between MVR and WTCR 
was determined. Finally, defining WTCR as "truth" for receiver-operator characteristic 
(ROC) analysis purposes, we determined the corresponding optimal cutoff for CONC by 
MVR. 
RESULTS 
WTCR criteria categorized 53 men (37.6%) and 25 women (16.6%) with CONC. Mean 
±SD MVR was 1.46±0.29 in men and f.34¢0.33 in women. There was single-quartile 
crossover in 84 (28.8%) subjects, 2-quartile in 32 (11.0%) and 3-quartile in 10 (3.4%), the 
remaining 166 (56.8%) subjects were stratified identically by WTCR and MVR. Correla- 
tion between MVR and WTCR for individual ranking of patients was r--0.32, p<0.001. 
MVR=1.45 was identified as the optimal threshhold for CONC by ROC analysis, with 
sensitivity=53.4% and specificity=72.9%. 
CONCLUSIONS 
Current linear-measurement criteria for CONC agree only modestly with the ratio of volu- 
metric LV mass to EDV with respect to stratifying patients. Volumetric criteria for CONC 
and their prognostic value remain to be more fully defined, but the linear WTCR is not 
interchangeable with MVR, a natural volumetric index of concentric remodeling. 
1140-51 Resul ts  o f  a Dose-Ranging Diagnostic Trial o f  Magnetic 
Resonance Angiography With MS-325, a Blood Pool 
Contrast  Agent ,  fo r  the  Detect ion of  Vascular  Occlusive 
Disease in the Aortoiliac Region 
Martin Leon, Emile Mohler, MS-325-09 Trial Group, Lenox Hi//Hospital, New York, New 
York, University of Pennsylvania Hospital, Phi/adelphi, Pennsylvania. 
BACKGROUND: MS-325 (EPIX Medical, Inc.) is a gadolinium-based blood pool contrast 
agent which provides substantial and durable enhancement of the arterial MR signal over 
that of the current axtrecellular gadolinium contrast agents. A dose-ranging diagnostic 
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trial has been completed to examine the accuracy of MS-325-enhanced MRA relative to 
non-contrast MRA for the detection of aortoiliac disease (AIOD). 
METHODS: In this 25 center, double-blind study, 233 patients with known or suspected 
peripheral vascular disease were administered either placebo or MS-325 for MRA of the 
aortoiliec region in comparison to the standard of reference, X-ray angiography (XRA). 
Patients received placebo or one of five doses of MS-325. 2D-TOF MRA images were 
acquired immediately prior to MS-325 administration. MRA image sets were examined 
and interpreted by three blinded readers. Two independent blinded readers read and 
interpreted the XRA images. AIOD was defined as >=50% stenosis in the abdominal 
aorta, common iliec, external lilac, or common femoral arteries. The sensitivity, specific- 
ity, and accuracy were determined for each group prior to and following MS-325 adminis- 
tration. 
RESULTS: The accuracy of MRA for diagnosis of AIOD prior to and with MS-325 
enhancement as a function of dose for the blinded read is shown below. 
CONCLUSIONS: At doses of 0.03 mmol/kg and above, MS-325 enhanced MRA pro- 
vided an approximate 20% increase in accuracy over non-contrast 2D-TOF MRA for 
diagnosing clinically significant AIOD. 
MRA Accuracy by Dose; Mean (Range) 
Placebo 0.005 0.01 0.03 0.05 0.07 
mmol/kg mmol/kg mmol/kg mmol/kg mmol/kg 
Patients 37 44 34 39 40 39 
% % % % % % 
MRA Accuracy 68 68 56 66 64 66 
non-contrast (65-72) (61-74) (47-66) (61-72) (55-77) (56-82) 
MRA Accuracy 0 72 75 88 90 83 
post-MS-325 (0-0) (61-82) (73-79) (81-91) (81-96) (74-89) 
1140-52 Is Magnetic Resonance Imaging a Rel iable Tool for 
Quantifying Aortic Valve Stenosis? 
Shelton D. Caruthers, Rosa Lin, Mary P. Watkins, Peggy Brown, Katherine Lehr, LaTish 
McKinney, Gregory M Lanza, Samuel A. Wickline, Washington University, SL Louis, 
Missouri, Philips Medical Systems, Best, The Netherlands. 
Background: The reliability of Magnetic Resonance Imaging (MRI) in quantifying aortic 
stenosis is backed by limited literature. Applications of the continuity equation have 
received even less attention, Thus, we compared valve sizes calculated with velocity- 
time integrals (VTI) measured proximal and distal to valves and pressure gradients using 
Doppler ultrasound and phase contrast MRI. 
Methods: In 12 patients, using the velocity encoding MR technique, quantitative flow 
images were acquired-oriented parallel to the aortic valve plane, positioned on the plane 
and 1.5cm above and below. From velocity and diameters measured on an offline work- 
station, VTI were calculated and used in the continuity equation to estimate the functional 
aortic valve area. Peak and mean pressure gradients were also calculated. All were com- 
pared, double-blinded, with ultrasound measurements taken just after the MR. 
Results: Measurements from the MRI flow images correlated with the same measure- 
ments from echo. Coefficients for the peak and mean pressure gradients were r = 0.951 
and r = 0.925, respectively (p<0.001). For VTI, r = 0.958 and r = 0.909 (p<0.00t) for the 
aorta and LV outflow tract. In these patients, aortic valve area, using echo, ranged from 
0.5 to 1.8 cm 2. Correlating significantly (r = 0.854, p<0.001), MRI values were 0.7 cm2to 
1.6 cm 2 (see figure). 
Conclusion: MRI can be used with the V'I'I approach to evaluate reliably and easily aor- 
tic valve area, comparable to Doppler, in patients with mild-to-severe valve disease. 
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1140-67 Rapid Evaluation of Right Ventriculer Volume end Mass 
Without Breath-Holding Using Real-Time Interactive 
Cardiac Magnetic Resonance Imaging System 
~;huichiro Kaii. Phillip C. Yang, Adam B. Kerr, Craig H. Meyer, John M. Pauly, Bob S. Hu, 
Kawasaki Medical School, Kurashiki, Japan, Stanford University $chco/ of Medicine, 
Stanford, California. 
Background: Precise determination of the degree of right-sided volume overload is 
important in evaluating cardiac or pulmonary diseases. While magnetic resonance imag- 
ing (MRI) provides accurate assessment of right ventricular (RV) function, previous tech- 
niques have been relatively slow and required ECG gating, in contrast, a newly 
developed cardiac MRI system allows continuous real-time dynamic acquisition and dis- 
play of any scan plane at up to 30 images/s without ECG gating or breath-holding. The 
purpose of this study was to validate RV measurements derived from the real-time car- 
diac MRI as compared with the well-validated conventional cine MRI. Methods and 
Results: Eighteen subjects underwent he real-time cardiac MRI and oine MRI in the 
short axis orientation on a standard 1.5T MRI scanner. Cine MRI were obtained with 
ECG and respiratory gating. Measurements were obtained of RV end-diastolic volume 
